key: cord-0950839-s5v74j3u authors: Aitken, Robert John title: COVID‐19 and male infertility: An update date: 2021-08-31 journal: Andrology DOI: 10.1111/andr.13098 sha: c40d780901f037c75c0ecfad4034f8db0cdb6550 doc_id: 950839 cord_uid: s5v74j3u The world was first alerted to the existence of a novel coronavirus (COVID-19) on December 31st , 2019. In the 2 years that have elapsed since the beginning of this outbreak, sporadic reports have emerged of an impact on male reproductive health. It is now timely to look at this information to see what conclusions can be drawn. The evidence collected to date clearly indicates that the virus can traverse the blood testes barrier and gain access to the seminiferous tubules. Depending on the severity of the infection, an impact on semen quality has been detected potentially influencing sperm morphology, motility, count and DNA integrity. Fortunately, the early signs are that these changes are potentially reversible with the passage of time. Whether the deleterious impact of COVID-19 infection reflect a direct impact of the virus on the germ line or, as suggested in the accompanying letter by Marin et al, are induced by the oxidative stress that accompanies the cytokine storm precipitated by this virus, is a key issue that now needs to be resolved. This article is protected by copyright. All rights reserved. To the Editor: Last year Andrology published an Opinion Article raising the possibility that COVID-19 virions might interact with human spermatozoa and disrupt male fertility. 1 This prediction was based upon a proteomic analysis of these cells, indicating that they possess the entire repertoire of receptors needed to support angiotensin signaling, including ACE2-the cellular entry point for coronavirus infection. Because the angiotensin system is known to play such an important role in the maintenance of sperm viability and function, it was proposed that contact with the virus would have adverse reproductive consequences for infected males. 1 It was also speculated that infection would lead to a series of detrimental changes in the male tract associated with the creation of significant oxidative stress. These changes include (i) the generation of reactive oxygen species (ROS) by the sperm mitochondria as these cells engage the intrinsic apoptotic pathway 2 ; (ii) an increase in local ROS generation as a result of sperm phagocytosis by leukocytes responding to elevated levels of angiotensin II 3 ; and (iii) oxidative stress created by the proinflammatory cytokine storm that accompanies COVID-19 infection. 4 The suggested involvement of oxidative stress in mediating the impact of COVID-19 on male reproductive competence has led Marin et al. 5 to advocate the potential benefits of antioxidant (astaxanthin) treatment in the accompanying Letter to the Editor. Now that we have been living with this virus for around 2 years, it may be good time to review the information that has come to light, to determine whether any evidence has emerged to support the proposed impacts of COVID-19 on sperm vitality and function, and whether oxidative stress is indeed a key contributor to any of the changes observed. At this point in our journey, it seems incontrovertible that the virus can gain access to the testes 6 possibly because the inflammatory response triggered by the virus disrupts the blood-testes barrier. The limitations associated with most of these investigations are small sample size, inter-patient variation in the severity of COVID-19 infection, and inadequate study design. None of the major studies conducted in this area present pre-infection data as a reference point and, instead, rely on cross-sectional comparisons with uninfected controls. One of the few published longitudinal studies where semen profile data were available before and after COVID-19 infection was a case report from an IVF clinic in India. 18 In this example, the male partner was normozoospermic prior to COVID-19 infection but revealed a dramatic decline in sperm number, motility, morphology, and DNA integrity when tested 1 month after this disease took hold. Moreover, this patient had still not recovered to pre-COVID levels when his semen was examined 4 months post infection. Fortunately, the prolonged suppression of semen quality following infection does not seem to be a consistent feature of this disease state. Several studies have not only confirmed a significant impact of infection on all aspects of semen quality but have also reported a progressive return to normality following infection. 19, 20 Again, much presumably depends on the severity of the disease and the extent to which spermatogenesis was impaired in the first instance. Andrology. 2021;1-3. wileyonlinelibrary.com/journal/andr COVID-19 and human spermatozoa -potential risks for infertility and sexual transmission? Phosphoinositide 3-kinase signalling pathway involvement in a truncated apoptotic cascade associated with motility loss and oxidative DNA damage in human spermatozoa Angiotensin II increases sperm phagocytosis by neutrophils in vitro: a possible physiological role in the bovine oviduct A multiple-hit hypothesis involving reactive oxygen species and myeloperoxidase explains clinical deterioration and fatality in COVID-19 A suggestion to overcome potential risks for infertility due to COVID-19: a response to Aitken. Andrology COVID-19 autopsy cases: detection of virus in endocrine tissues T lymphocytes and testicular immunity: a new insight into immune regulation in testes Absence of SARS-CoV-2 in semen of a COVID-19 patient cohort Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: a crosssectional, pilot study Clinical characteristics and results of semen tests among men with coronavirus disease 2019 SARS-CoV-2 infection and human semen: possible modes of contamination and transmission Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients Does COVID-19 worsen the semen parameters? Early results of a tertiary healthcare center The relationship of serum testosterone levels with the clinical course and prognosis of COVID-19 disease in male patients: a prospective study No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: a perspective and urogenital evaluation Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 Impaired spermatogenesis in COVID-19 patients Post-COVID-19 associated decline in long-term male fertility and embryo quality during assisted reproductive technology Semen parameters in men recovered from COVID-19 COVID-19 and male reproductive function: a prospective, longitudinal cohort study Effects of moderate COVID-19 infection on semen oxidative status and parameters 14 and 120 days after diagnosis Effect of COVID-19 on male reproductive system -a systematic review Should we be measuring DNA damage in human spermatozoa? New light on an old question Does SARS-CoV-2 threaten male fertility?